IV COURSE ON UPDATES IN THE DIAGNOSIS AND TREATMENT OF THYMIC TUMORS

IV COURSE ON UPDATES IN THE DIAGNOSIS AND TREATMENT OF THYMIC TUMORS


 

Thymic tumors are rare, and the most common type is thymoma, which grows slowly but is malignant in nature. Their prognosis depends on the degree of invasion and the possibility of complete resection. The scarcity of cases means that clinical experience is limited and scattered, and the available literature is mainly based on retrospective series and single-center data, making it difficult to compare results due to a lack of unified classifications.

At the national level, the Thoracic Surgery Service and the Neuromuscular Pathology Unit, led by Dr. Isabel Illa, have been a reference in the treatment of these tumors and the associated paraneoplastic syndromes, creating the country’s first multidisciplinary thymic tumor committee. As a result of this experience, the Update Course on the Diagnosis and Treatment of Thymic Tumors has been organized, with its 4th edition taking place on October 16 and 17, aimed at all professionals involved in their multidisciplinary care.



CONFERENCE PROGRAM

 

COURSE DIRECTOR
Dr. Juan Carlos Trujillo
Joint Thoracic Surgery. Hospital de la Santa
Creu i Sant Pau/Hospital del Mar

ORGANIZING COMITEE
Dr. Josep Belda
Dr. Elisabeth Martínez
Dr. Alejandra Libreros
Dr. Georgina Planas
Dr. Jorge Hernández
Dr. Stephania Chavarria
Dr. Georgina Ros
Dr. Leandro Grando
Dr. Albert Rodriguez
Dr. Rafael Aguiló
Joint Thoracic Surgery Service Hospital de la
Santa Creu i Sant Pau/Hospital del Mar

OBJECTIVE
To update theoretical and practical knowledge
on the diagnosis and treatment of
thymic tumors, both with and without associated
Myasthenia Gravis (MG).

COURSE VENUES
• October 16, 2025 – Sessions streamed
from Sala Pau Gil, Modernist Complex, Hospital
de la Santa Creu i Sant Pau
• October 17, 2025 – Online streaming via
the course website and in-person attendance
at the 4th floor of Hospital de la Santa Creu i
Sant Pau

 

Last Update: 26/09/2025

Asset Publisher

null aaa

Asset Publisher
09/07/2017
La Fundación Mutua Madrileña premia al Grup d’Oncogènesis i Antitumorals de l’IIB Sant Pau
El projecte “Terapia dirigida para la eliminación selectiva de células madre metastáticas CXCR4+ en cáncer de endometrio” que lidera la Dra. Maria Virtudes Céspedes Navarro, investigadora del Grup d’Oncogènesis i Antitumorals de l’IIB Sant Pau, ha estat escollit per rebre un dels 18 ajuts que concedeix la Fundación Mutua Madrileña. El projecte s’ha finançat amb 140.000 €.

L’acte d’entrega va tenir lloc el passat 6 de juliol durant la XIV Convocatoria Anual de Ayudas a la Investigación Científica en Salud, on es van destinar 1,7 milions d’euros per a donar suport a 18 estudis clínics dirigits a la millora dels tractaments mèdics que es desenvoluparan en diferents centres d’investigació de tot l’Estat.

Més informació

 

Contacte Cirurgia Toracica

Ubicació i contacte
Ubicació

Secretaria de Pneumologia i Cirurgia Toràcica

Despatxos: 4ª planta mòdul 2

Sala d’hospitalització: sala C2

Consultes externes: planta 3ª, mòdul 5.

Contacte

Servei de Cirurgia Toràcica

Telèfon: 93 556 57 44